New incident report
Incident Report Number: 2020-0397
Registrant Reference Number: 2514318
Registrant Name (Full Legal Name no abbreviations): Bell Laboratories, Inc.
Address: 3699 Kinsman Blvd
City: Madison
Prov / State: WI
Country: USA
Postal Code: 53704
Domestic Animal
Country: CANADA
Prov / State: ONTARIO
PMRA Registration No. PMRA Submission No. EPA Registration No. 12455-76
Product Name: Contrac Rodenticide Ready-To-Use Place Pacs
PMRA Registration No. PMRA Submission No. EPA Registration No. 12455-79
Product Name: Contrac All-Weather Blox (non-specific)
Yes
Unknown
Site: Res. - In Home / Rés. - à l'int. maison
Unknown
Animal's Owner
Dog / Chien
Mixed Breed
1
Female
1.50
70.00
lbs
Oral
Unknown / Inconnu
>8 hrs <=24 hrs / > 8 h < = 24 h
System
Unknown / Inconnu
Yes
Unknown
Unknown/Inconnu
Accidental ingestion/Ingestion accident.
(eg. description of the frequency and severity of the symptoms
On 04-Sep-2019 a pet owner reported that on 31-Aug-2019 her dog had access to a crawl space and may have ingested up to 5 Contrac Rodenticide Ready-To-Use Place Pacs. No ingestion was witnessed but the color of the product was noted in the dog's stool starting on 31-Aug-2019 and persisted for several days. Signs to monitor for were discussed as well as checking for additional product the dog may have had access to given persistent stool discoloration. On 05-Sep-2019 the owner reported the dog developed bleeding from one of its nostrils. Veterinary evaluation was recommended. Approximately two hours later the treating veterinarian reported the dog presented with bleeding from the right nostril but no other evidence of bleeding. The owner had reported to the veterinarian that the dog had shifting leg lameness of unspecified duration. Typical signs of anticoagulant toxicity and standard treatments and diagnostics were discussed. On 09-Sep-2019 the pet owner reported the dog likely ingested up to 5 blocks of Contrac All-Weather Blox rather than the place pack product initially reported. No changes to treatment recommendations were made since the product contain the same active ingredient. No further information was received in this case.
Moderate
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.